ALFA FinderBSE filing, NSE: ZEEL. Summary written from the filing by ALFA Finder's alert engine.
Zee Entertainment Enterprises Ltd: key numbers
- Share price
- ₹71.72
- Market cap
- ₹6,889 Cr
- Revenue (annual)
- ₹8,099 Cr
- Net profit (annual)
- ₹273.1 Cr
- P/E (TTM)
- 38.9×Sector 28.9×
- Promoter holding
- 3.99%+0.00% QoQ
- FII holding
- 18.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zee Entertainment Enterprises Ltd
All →Zee Entertainment Enterprises Board Meeting Date
Zee Entertainment has called a board meeting for 12 November 2026 to address the recent share price decline. Buyback and interim dividend proposals are under consideration, with no decision yet taken.
Zee Entertainment Enterprises Investor Presentation: Key Takeaways
Q2 FY27 operating revenue rose 13% YoY; EBITDA INR708m (3.2% margin) and PAT INR456m. FIFA-driven digital surge, but margins were hit by sports and new-initiative spends.
Zee Entertainment Enterprises Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue rose 13% YoY to ₹22,246 Mn on digital and FIFA, but EBITDA margin fell to 3.2% (7.4% a year ago) and PAT fell 40%.
Zee Entertainment Enterprises Other Announcement
Zee Entertainment updated its authorised KMP list for Reg 30 disclosures, effective 2 November 2026, after a Company Secretary change. No money or business event is involved.
Zee Entertainment Enterprises Management Change
Zee Entertainment appointed Sangeeta Shetty as Chief Compliance Officer and Company Secretary effective 2 November 2026, replacing Ashish Agarwal who resigned. No monetary value is involved.
Zee Entertainment Enterprises Results Update
Zee Entertainment filed an earnings release for Q2 FY27 on unaudited standalone and consolidated results. Operating revenue rose 13% YoY to Rs 22,246 Mn with EBITDA of Rs 708 Mn.
Other product launch announcements
All →Bharat Forge Product Launch
Bharat Forge's defence subsidiary KSSL unveiled the 120mm Rapid Attack Mortar System for Indian Armed Forces and international customers. No order value or contract was announced.
Lupin Product Launch
Lupin announced the European launch of its biosimilar Ranibizumab (Ranluspec) via commercial partner Sandoz. The launch covers Europe excluding Germany following European Commission approval.
LTM Product Launch
LTM publishes AI-QEM, its Quantum Error Mitigation tool, in IBM's Quantum Functions Catalog, becoming the first global systems integrator to do so.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.